Aspen showing upside to R204 despite Trump pulling funds from SAOk this isn't the best formation.
We have the price above 20MA but still below 200MA.
On the other hand, we have a solid bottom formed and a W Formation along with a Box Formation with it.
So with the pull back and the retest, we could get a bounce up which will send the price to potentially R
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2 ZAR
−1.08 B ZAR
43.36 B ZAR
354.33 M
About Aspen Pharmacare Holdings Limited
Sector
Industry
CEO
Stephen Bradley Saad
Website
Headquarters
Durban
Founded
1850
ISIN
ZAE000066692
FIGI
BBG000BP97L3
Aspen Pharmacare Holdings Ltd. manufactures and supplies branded and generic pharmaceutical products. It operates through the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals segment consists of the following business sub segments: Sterile Focused Brands, which includes the Anaesthetics and Thrombosis portfolios; and Regional Brands, which are products that are managed on a regional basis. The Manufacturing segment focuses on the following business sub segments: Active Pharmaceutical Ingredients, which involved in API Chemicals business and non-heparin biochemical API business; Heparin, which refers to the full value chain contribution from all heparin containing products; FDF Steriles, which includes all FDF sterile sales; and FDF Other, which consists of all non-sterile FDF products. The company was founded by Michael Guy Attridge and Stephen Bradley Saad in 1850 and is headquartered in Durban, South Africa.
Related stocks
ASPEN nearly ready for a strong shot down to R151.06!Inv Cup and Handle has been forming on Aspen.
The price is >20 and 200 showing that the momentum is down.
I am eagerly waiting for a strong break below, before I look at getting into a long holding short (sell trade).
My first target will be at R151.06
Our opinion on the current state of ASPEN(APN)Aspen (APN) is a global pharmaceutical company that operates in 150 countries, offering a wide range of specialty and branded products designed to address various acute and chronic medical conditions. The company has 25 manufacturing facilities across 15 sites, with its primary product categories in
Aspen Seeking to Push into Weekly Cycle HighAspen is consolidating in a symmetrical triangle, it has good support in the triangle and the median line of Pitchfork. On the weekly perspective we are in time for a half cycle correction hence I expect the price to resolve upwards.
The stop-loss is R185.41
UPDATE: Target Reached Aspen R206.03 - Next target higherSymmetrical Triangle was a a text book trade. The previous trend was up. Price broke above the apex 3/4s in and the momentum continued up.
We had further indicators of confirmation for upside to come.
Price>20
Price>200
Target 1 R206.03
So what now? Well we can expect somewhat a consolidation, an
Our opinion on the current state of APNAspen Pharmacare Holdings Limited (APN), a leading pharmaceutical company, operates globally, distributing its products across 150 countries. The company's diversified product range targets various acute and chronic medical conditions, with a focus on thrombosis, anaesthetics, cytotoxics, and nutrit
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SEDM
iShares IV PLC - iShares MSCI EM IMI Screened UCITS ETF Unhedged USDWeight
0.02%
Market value
1.24 M
USD
Explore more ETFs
Frequently Asked Questions
The current price of APN is 9,144 ZAC — it has decreased by −2.59% in the past 24 hours. Watch Aspen Pharmacare Holdings Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on JSE exchange Aspen Pharmacare Holdings Limited stocks are traded under the ticker APN.
APN stock has fallen by −3.77% compared to the previous week, the month change is a −8.38% fall, over the last year Aspen Pharmacare Holdings Limited has showed a −46.84% decrease.
We've gathered analysts' opinions on Aspen Pharmacare Holdings Limited future price: according to them, APN price has a max estimate of 12,100.00 ZAC and a min estimate of 11,300.00 ZAC. Watch APN chart and read a more detailed Aspen Pharmacare Holdings Limited stock forecast: see what analysts think of Aspen Pharmacare Holdings Limited and suggest that you do with its stocks.
APN stock is 4.97% volatile and has beta coefficient of 0.58. Track Aspen Pharmacare Holdings Limited stock price on the chart and check out the list of the most volatile stocks — is Aspen Pharmacare Holdings Limited there?
Today Aspen Pharmacare Holdings Limited has the market capitalization of 41.68 B, it has increased by 0.76% over the last week.
Yes, you can track Aspen Pharmacare Holdings Limited financials in yearly and quarterly reports right on TradingView.
Aspen Pharmacare Holdings Limited is going to release the next earnings report on Mar 3, 2026. Keep track of upcoming events with our Earnings Calendar.
APN net income for the last half-year is −3.47 B ZAR, while the previous report showed 2.39 B ZAR of net income which accounts for −245.35% change. Track more Aspen Pharmacare Holdings Limited financial stats to get the full picture.
Yes, APN dividends are paid annually. The last dividend per share was 2.11 ZAR. As of today, Dividend Yield (TTM)% is 2.25%. Tracking Aspen Pharmacare Holdings Limited dividends might help you take more informed decisions.
As of Nov 22, 2025, the company has 9.56 K employees. See our rating of the largest employees — is Aspen Pharmacare Holdings Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aspen Pharmacare Holdings Limited EBITDA is 10.23 B ZAR, and current EBITDA margin is 22.12%. See more stats in Aspen Pharmacare Holdings Limited financial statements.
Like other stocks, APN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aspen Pharmacare Holdings Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aspen Pharmacare Holdings Limited technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aspen Pharmacare Holdings Limited stock shows the sell signal. See more of Aspen Pharmacare Holdings Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.









